HCA Healthcare, Inc.
Michael J Schlosser (EVP and Chief Clinical Officer) reports HCA insider transactions
About this filing
HCA Healthcare, Inc. (HCA) filed Form 3 (initial insider holdings) with the SEC on Sep 11, 2026.
Key facts
- Insider
- Michael J Schlosser · EVP and Chief Clinical Officer
No transactions reported; holdings only.
Footnotes
- F1 Includes 170.1027 shares acquired under the Issuer's employee stock purchase plans.
- F2 The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
- F3 The stock appreciation rights vested in four equal annual installments beginning on May 3, 2018.
- F4 The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.
- F5 The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.
- F6 The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021.
- F7 The stock appreciation rights vested in four equal annual installments beginning on February 3, 2022.
- F8 The stock appreciation rights vested in four equal annual installments beginning on July 22, 2022.
- F9 The stock appreciation rights vested in four equal annual installments beginning on January 28, 2023.
- F10 The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024.
- F11 The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.
- F12 The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026.
- F13 The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.
More HCA filings
- 424B3
Filed Nov 2, 2026
- 10-Q
Filed Oct 29, 2026
- 144
Filed Oct 29, 2026
- 8-K
Filed Oct 27, 2026
- 4
Filed Aug 28, 2026
- 8-K
Filed Jul 29, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.